Search
for

    GlossaryPremature Ovarian Failure (Primary Ovarian Insufficiency)

    ovaries stop functioning normally before age 40, causing infertility

    Premature Ovarian Failure (POF), also known as Primary Ovarian Insufficiency, is a condition where a woman's ovaries stop functioning normally before the age of 40. This leads to reduced production of estrogen and other hormones, causing irregular or absent menstrual periods, infertility, and symptoms similar to menopause, such as hot flashes and vaginal dryness.

    Related Terms

    Learn

    5 / 9 results

      learn Latanoprost

      glaucoma medication with hair follicle stimulant effects

      learn Tretinoin

      the gold standard retinoid in dermatology that's also helpful for hair regrowth alongside Minoxidil

      learn Castor oil

      a traditional, natural remedy touted for promoting scalp health and hair growth

      learn Bicalutamide

      a nonsteroidal anti-androgen, most commonly used orally for women

    Research

    5 / 1000+ results

    Community Join

    5 / 289 results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 4 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community DHT levels after 4 weeks of Fina and 8 weeks of Fina + 4 weeks of Duta

      in Update  35 upvotes 5 years ago
      The user reported early stage diffuse hair thinning and increased DHT levels after 4 weeks on Finasteride and 8 weeks on Finasteride plus 4 weeks on Dutasteride, despite the medications being authentic and stored properly. They are considering increasing their Dutasteride dosage due to the lack of side effects and are unsure if the treatment is helping their hair.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  134 upvotes 8 months ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.